Loading... Please wait...

Alnylam Pharmaceuticals, Inc. (ALNY) Financials

Currency in USD Disclaimer
$248.68 $1.07 (0.43%)
$245.48
$249.67
$141.98
$252.87
Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $1.83 B $1.04 B $844.29 M $492.85 M $219.75 M $74.91 M $89.91 M $47.16 M $41.10 M $50.56 M
Cost of Revenue $310.41 M $168.82 M $140.14 M $78.05 M $25.06 M $1.80 M $0.00 $0.00 $0.00 $0.00
Gross Profit $1.52 B $868.60 M $704.14 M $414.80 M $194.69 M $73.11 M $89.91 M $47.16 M $41.10 M $50.56 M
Gross Profit Ratio 0.83 0.84 0.83 0.84 0.89 0.98 1 1 1 1
Research and Development Expenses $1.00 B $883.02 M $792.16 M $654.82 M $655.11 M $505.42 M $390.64 M $382.39 M $276.50 M $190.25 M
General & Administrative Expenses $795.65 M $770.66 M $620.64 M $588.42 M $479.01 M $382.36 M $199.37 M $89.35 M $60.61 M $44.53 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $795.65 M $770.66 M $620.64 M $588.42 M $479.01 M $382.36 M $199.37 M $89.35 M $60.61 M $44.53 M
Other Expenses -$17.74 M -$109.37 M -$2.05 M $45.53 M $20.73 M $4.17 M -$3.02 M $6.17 M $76,000.00 $1.82 M
Operating Expenses $1.80 B $1.65 B $1.41 B $1.24 B $1.13 B $887.78 M $590.00 M $471.75 M $337.11 M $234.78 M
Cost And Expenses $2.11 B $1.82 B $1.55 B $1.32 B $1.16 B $889.58 M $590.00 M $471.75 M $337.11 M $234.78 M
Interest Income $95.56 M $24.81 M $1.58 M $11.81 M $33.45 M $29.26 M $12.24 M $8.31 M $5.86 M $2.56 M
Interest Expense $121.22 M $155.97 M $143.02 M $84.50 M $0.00 $29.26 M $12.24 M $8.31 M $5.86 M $2.56 M
Depreciation & Amortization $54.05 M -$109.37 M -$471,000.00 $57.33 M $54.37 M $6.44 M $13.37 M $15.13 M $19.05 M $11.93 M
EBITDA -$228.12 M -$894.44 M -$709.12 M -$771.10 M -$939.43 M -$835.24 M -$500.09 M -$424.59 M -$296.01 M $36.55 M
EBITDA Ratio -0.12 -0.86 -0.84 -1.56 -4.27 -11.15 -5.56 -9 -7.2 0.72
Operating Income -$282.18 M -$785.07 M -$708.65 M -$828.44 M -$939.43 M -$814.67 M -$500.09 M -$424.59 M -$296.01 M -$404.98 M
Operating Income Ratio -0.15 -0.76 -0.84 -1.68 -4.27 -10.88 -5.56 -9 -7.2 -8.01
Total Other Income/Expenses Net -$151.34 M -$341.92 M -$143.49 M -$27.16 M $54.18 M $24.74 M -$3.02 M $6.17 M $76,000.00 -$218.95 M
Income Before Tax -$433.52 M -$1.13 B -$852.14 M -$855.60 M -$885.25 M -$760.67 M -$490.87 M -$410.11 M -$290.07 M -$400.60 M
Income Before Tax Ratio -0.24 -1.09 -1.01 -1.74 -4.03 -10.15 -5.46 -8.7 -7.06 -7.92
Income Tax Expense $6.73 M $4.16 M $680,000.00 $2.68 M $863,000.00 $823,000.00 -$25.60 M -$23.44 M -$24.91 M -$40.21 M
Net Income -$440.24 M -$1.13 B -$852.82 M -$858.28 M -$886.12 M -$761.50 M -$490.87 M -$410.11 M -$290.07 M -$360.40 M
Net Income Ratio -0.24 -1.09 -1.01 -1.74 -4.03 -10.17 -5.46 -8.7 -7.06 -7.13
EPS -3.52 -9.3 -7.2 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85
EPS Diluted -3.52 -9.3 -7.2 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85
Weighted Average Shares Out $124.91 M $121.69 M $118.45 M $114.99 M $109.26 M $100.59 M $90.55 M $85.60 M $83.99 M $74.28 M
Weighted Average Shares Out Diluted $124.91 M $121.69 M $118.45 M $114.99 M $109.26 M $100.59 M $90.55 M $85.60 M $83.99 M $74.28 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.